| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDS LTD | 2,000,000 | 112,920,000 | 9.67% | ||
| 2 | MEDICINES CO | 2,500,000 | 94,900,000 | 8.13% | ||
| 3 | ASTRAZENECA PLC | 2,500,000 | 79,550,000 | 6.81% | ||
| 4 | LIVANOVA PLC | 1,000,000 | 60,780,000 | 5.21% | ||
| 5 | MYLAN N V | 1,500,000 | 60,390,000 | 5.17% | ||
| 6 | NUVASIVE INC COM | 1,100,000 | 53,042,000 | 4.54% | ||
| 7 | GENOMIC HEALTH INC COM | 2,450,000 | 51,842,000 | 4.44% | ||
| 8 | ORTHOFIX INTERNATIONAL NV | 1,500,000 | 50,625,000 | 4.34% | ||
| 9 | EXPRESS SCRIPTS HLDG CO | 600,000 | 48,576,000 | 4.16% | ||
| 10 | SELECT MED HLDGS CORP COM | 4,350,000 | 46,937,000 | 4.02% | ||
| 11 | LABORATORY CORP AMER HLDGS | 400,000 | 43,388,000 | 3.72% | ||
| 12 | MEAD JOHNSON NUTRITION CO | 600,000 | 42,240,000 | 3.62% | ||
| 13 | UNIVERSAL AMERN CORP NEW | 5,875,000 | 40,185,000 | 3.44% | ||
| 14 | MASIMO CORP COM | 1,000,000 | 38,560,000 | 3.30% | ||
| 15 | ARIAD PHARMACEUTICALS INC | 5,533,118 | 32,313,000 | 2.77% | ||
| 16 | NEKTAR THERAPEUTICS COM | 2,250,000 | 24,660,000 | 2.11% | ||
| 17 | SEQUENOM INC | 11,750,000 | 20,563,000 | 1.76% | ||
| 18 | CROSS CTRY HEALTHCARE INC COM | 1,493,765 | 20,330,000 | 1.74% | ||
| 19 | ALNYLAM PHARMACEUTICALS INC | 250,000 | 20,090,000 | 1.72% | ||
| 20 | HMS HOLDINGS CORPORATION | 2,179,900 | 19,118,000 | 1.64% | ||
| 21 | ARENA PHARMACEUTICALS INC | 9,750,000 | 18,623,000 | 1.60% | ||
| 22 | TENET HEALTHCARE CORP THC | 500,000 | 18,460,000 | 1.58% | ||
| 23 | KINDRED HEALTHCARE INC | 1,100,000 | 17,325,000 | 1.48% | ||
| 24 | INNOCOLL AG | 1,111,111 | 14,089,000 | 1.21% | ||
| 25 | QUEST DIAGNOSTICS INC | 218,500 | 13,431,000 | 1.15% | ||
| 26 | AMARIN CORP PLC | 6,500,000 | 12,545,000 | 1.07% | ||
| 27 | ABBOTT LABS | 300,000 | 12,066,000 | 1.03% | ||
| 28 | DURECT CORP | 6,000,000 | 11,700,000 | 1.00% | ||
| 29 | BIOSCRIP INC | 6,000,000 | 11,220,000 | 0.96% | ||
| 30 | ORASURE TECHNOLOGIES INC | 2,000,000 | 8,880,000 | 0.76% | ||
| 31 | PROTALIX BIOTHERAPEUTICS INC | 7,274,577 | 8,584,000 | 0.74% | ||
| 32 | EPIRUS BIOPHARMA | 1,847,500 | 8,166,000 | 0.70% | ||
| 33 | Catabasis Pharmaceuticals Inc | 1,000,000 | 8,090,000 | 0.69% | ||
| 34 | INVITAE CORP | 894,014 | 6,455,000 | 0.55% | ||
| 35 | INSULET CORPORATION | 245,000 | 6,348,000 | 0.54% | ||
| 36 | PROTALIX BIOTHERAPEUTICS INC | 9,000,000 | 6,182,000 | 0.53% | PRN | |
| 37 | GENMARK DIAGNOSTICS INC COM | 724,097 | 5,699,000 | 0.49% | ||
| 38 | BIOLASE INC | 5,332,394 | 4,799,000 | 0.41% | ||
| 39 | VERACYTE INC | 910,334 | 4,269,000 | 0.37% | ||
| 40 | ANGIODYNAMICS INC | 258,183 | 3,405,000 | 0.29% | ||
| 41 | UNILIFE CORP | 2,750,000 | 2,695,000 | 0.23% | ||
| 42 | CARDICA INC | 8,374,846 | 2,412,000 | 0.21% | ||
| 43 | Catalyst Biosciences | 192,935 | 899,000 | 0.08% | ||
| 44 | ASTRAZENECA PLC | 1,841,173 | 3,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001546927-15-000279, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
